114 related articles for article (PubMed ID: 15899391)
1. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
Gadzicki D; von Neuhoff N; Steinemann D; Just M; Büsche G; Kreipe H; Wilkens L; Schlegelberger B
Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
[TBL] [Abstract][Full Text] [Related]
2. Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.
Asif M; Hussain A; Wali A; Ahmed N; Ali I; Iqbal Z; Amir M; Shafiq M; Rasool M
Anal Cell Pathol (Amst); 2021; 2021():4909012. PubMed ID: 34422550
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review.
Li Y; Zhang Y; Meng X; Chen S; Wang T; Zhang L; Ma X
Medicine (Baltimore); 2024 Jan; 103(3):e36728. PubMed ID: 38241589
[TBL] [Abstract][Full Text] [Related]
4. The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report.
Ursuleac I; Colita A; Adam T; Jardan C; Ilea A; Coriu D
J Med Life; 2013 Mar; 6(1):34-7. PubMed ID: 23599815
[TBL] [Abstract][Full Text] [Related]
5. A chronic myeloid leukemia case with a unique variant Philadelphia translocation: t(9;22;21)(q34;q11;p12).
Al-Achkar W; Wafa A; Moassass F; Liehr T
Oncol Lett; 2012 May; 3(5):1027-1029. PubMed ID: 22783385
[TBL] [Abstract][Full Text] [Related]
6. The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile.
Eide CA; Adrian LT; Tyner JW; Mac Partlin M; Anderson DJ; Wise SC; Smith BD; Petillo PA; Flynn DL; Deininger MW; O'Hare T; Druker BJ
Cancer Res; 2011 May; 71(9):3189-95. PubMed ID: 21505103
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia.
San José-Eneriz E; Agirre X; Jiménez-Velasco A; Cordeu L; Martín V; Arqueros V; Gárate L; Fresquet V; Cervantes F; Martínez-Climent JA; Heiniger A; Torres A; Prósper F; Roman-Gomez J
Eur J Cancer; 2009 Jul; 45(10):1877-89. PubMed ID: 19403302
[TBL] [Abstract][Full Text] [Related]
8. Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.
Aichberger KJ; Mayerhofer M; Krauth MT; Vales A; Kondo R; Derdak S; Pickl WF; Selzer E; Deininger M; Druker BJ; Sillaber C; Esterbauer H; Valent P
Cancer Res; 2005 Oct; 65(20):9436-44. PubMed ID: 16230407
[TBL] [Abstract][Full Text] [Related]
9. The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells.
Bozkurt S; Özkan T; Özmen F; Baran Y; Sunguroğlu A; Kansu E
Hematology; 2013 Jul; 18(4):217-23. PubMed ID: 23394612
[TBL] [Abstract][Full Text] [Related]
10. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases.
Reichard KK; Kang H; Robinett S
Mod Pathol; 2011 Dec; 24(12):1606-11. PubMed ID: 21822204
[TBL] [Abstract][Full Text] [Related]
11. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
Wiertz EJ; Jones TR; Sun L; Bogyo M; Geuze HJ; Ploegh HL
Cell; 1996 Mar; 84(5):769-79. PubMed ID: 8625414
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
An X; Tiwari AK; Sun Y; Ding PR; Ashby CR; Chen ZS
Leuk Res; 2010 Oct; 34(10):1255-68. PubMed ID: 20537386
[TBL] [Abstract][Full Text] [Related]
13. Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients.
Szych CM; Liesveld JL; Iqbal MA; Li L; Siebert S; Asmus C; O'Malley J; Lee A; Wang N
Cancer Genet Cytogenet; 2007 Apr; 174(2):132-7. PubMed ID: 17452255
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.
Bradshaw DM; Arceci RJ
J Clin Oncol; 1998 Nov; 16(11):3674-90. PubMed ID: 9817290
[TBL] [Abstract][Full Text] [Related]
15. Isodicentric Philadelphia Chromosome: A Rare Chromosomal Aberration in Imatinib-Resistant Chronic Myelogenous Leukemia Patients - Case Report with Review of the Literature.
Ramachandran KC; Narayanan G; Nair SG; Thambi SM; Kamala LH; Gopinath P; Sreedharan H
Cytogenet Genome Res; 2016; 150(3-4):273-280. PubMed ID: 28253493
[TBL] [Abstract][Full Text] [Related]
16. Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036.
Chan WW; Wise SC; Kaufman MD; Ahn YM; Ensinger CL; Haack T; Hood MM; Jones J; Lord JW; Lu WP; Miller D; Patt WC; Smith BD; Petillo PA; Rutkoski TJ; Telikepalli H; Vogeti L; Yao T; Chun L; Clark R; Evangelista P; Gavrilescu LC; Lazarides K; Zaleskas VM; Stewart LJ; Van Etten RA; Flynn DL
Cancer Cell; 2011 Apr; 19(4):556-68. PubMed ID: 21481795
[TBL] [Abstract][Full Text] [Related]
17. Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia.
Bixby D; Talpaz M
Leukemia; 2011 Jan; 25(1):7-22. PubMed ID: 21102425
[TBL] [Abstract][Full Text] [Related]
18. Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML.
Beach DF; Barnoski BL; Aviv H; Patel V; Schwarting R; Strair R; Lachant NA
Cancer Genet; 2012 Dec; 205(12):665-8. PubMed ID: 23168243
[TBL] [Abstract][Full Text] [Related]
19. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Reid BJ; Li X; Galipeau PC; Vaughan TL
Nat Rev Cancer; 2010 Feb; 10(2):87-101. PubMed ID: 20094044
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
Podgornik H; Debeljak M; Zontar D; Cernelc P; Prestor VV; Jazbec J
Cancer Genet Cytogenet; 2007 Oct; 178(1):77-81. PubMed ID: 17889714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
